scholarly journals The clinical and cost effectiveness of adapted dialectical behaviour therapy (DBT) for bipolar mood instability in primary care (ThrIVe-B programme): a feasibility study

Trials ◽  
2018 ◽  
Vol 19 (1) ◽  
Author(s):  
Kim Wright ◽  
Alyson Dodd ◽  
Fiona C Warren ◽  
Antonieta Medina-Lara ◽  
Rod Taylor ◽  
...  
Keyword(s):  
Primary Care ◽  
Cost Effectiveness ◽  
Feasibility Study ◽  
Behaviour Therapy ◽  
Dialectical Behaviour Therapy ◽  
Mood Instability

Cost-Effectiveness of Dialectical Behaviour Therapy for Borderline Personality Disorder

2017 ◽  
pp. 496-514
Author(s):  
Roy Krawitz ◽  
Erin M. Miga
Keyword(s):  
Cost Effectiveness ◽  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Service Provision ◽  
Borderline Personality ◽  
Evidence Based ◽  
Behaviour Therapy ◽  
Dialectical Behaviour Therapy ◽  
Level 1 ◽  
Meta Analyses

This chapter aims to provide Dialectical Behaviour Therapy (DBT) cost-effectiveness information to assist funders, administrators, and providers in making decisions about borderline personality disorder (BPD) service provision. It provides brief overviews of BPD service provision challenges, how they relate to DBT and of DBT adherence, and current cost effectiveness research of DBT. DBT is the treatment for borderline personality disorder that offers Level 1 (highest level) evidence of efficacy and effectiveness, but data on cost-effectiveness is variable, limited, and largely descriptive; however, it is the only treatment with sufficient data for meta-analyses. Despite the limited existing data, DBT currently offers an evidence-based option that is likely to meet the financial objectives of funders, economists, accountants, administrators, providers, and consumers.

scholarly journals Preventing mental health symptoms in adolescents using dialectical behaviour therapy skills group: a feasibility study

2017 ◽  
Vol 23 (1) ◽  
pp. 70-85 ◽  
Author(s):  
Rowan Burckhardt ◽  
Vijaya Manicavasagar ◽  
Frances Shaw ◽  
Andrea Fogarty ◽  
Philip J. Batterham ◽  
...  
Keyword(s):  
Mental Health ◽  
Feasibility Study ◽  
Behaviour Therapy ◽  
Mental Health Symptoms ◽  
Health Symptoms ◽  
Dialectical Behaviour Therapy ◽  
Skills Group ◽  
Group A

scholarly journals Refractory depression – cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial

BJPsych Open ◽  
2019 ◽  
Vol 5 (05) ◽  
Author(s):  
James Shearer ◽  
Thomas R. Lynch ◽  
Rampaul Chamba ◽  
Susan Clarke ◽  
Roelie J. Hempel ◽  
...  
Keyword(s):  
Economic Evaluation ◽  
Cost Effectiveness ◽  
Cost Effective ◽  
British Isles ◽  
Behaviour Therapy ◽  
Dialectical Behaviour Therapy ◽  
Refractory Depression ◽  
Use Of Resources ◽  
Life Years ◽  
The Uk

BackgroundRefractory depression is a major contributor to the economic burden of depression. Radically open dialectical behaviour therapy (RO DBT) is an unevaluated new treatment targeting overcontrolled personality, common in refractory depression, but it is not yet known whether the additional expense of RO DBT is good value for money.AimsTo estimate the cost-effectiveness of RO DBT plus treatment as usual (TAU) compared with TAU alone in people with refractory depression (trial registration: ISRCTN85784627).MethodWe undertook a cost-effectiveness analysis alongside a randomised trial evaluating RO DBT plus TAU versus TAU alone for refractory depression in three UK secondary care centres. Our economic evaluation, 12 months after randomisation, adopted the perspective of the UK National Health Service (NHS) and personal social services. It evaluated cost-effectiveness by comparing the net cost of RO DBT with the net gain in quality-adjusted life-years (QALYs), estimated using the EQ-5D-3L measure of health-related quality of life.ResultsThe additional cost of RO DBT plus TAU compared with TAU alone was £7048 and was associated with a difference of 0.032 QALYs, yielding an incremental cost-effectiveness ratio (ICER) of £220 250 per QALY. This ICER was well above the National Institute for Health and Care Excellence (NICE) upper threshold of £30 000 per QALY. A cost-effectiveness acceptability curve indicated that RO DBT had a zero probability of being cost-effective compared with TAU at the NICE £30 000 threshold.ConclusionsIn its current resource-intensive form, RO DBT is not a cost-effective use of resources in the UK NHS.Declaration of interestR.H. is co-owner and director of Radically Open Ltd, the RO DBT training and dissemination company. D.K. reports grants outside the submitted work from the National Institute for Health Research (NIHR). T.L. receives royalties from New Harbinger Publishing for sales of RO DBT treatment manuals, speaking fees from Radically Open Ltd, and a grant outside the submitted work from the Medical Research Council. He was co-director of Radically Open Ltd between November 2014 and May 2015 and is married to Erica Smith-Lynch, the principal shareholder and one of two directors of Radically Open Ltd. H.O'M. reports personal fees outside the submitted work from the Charlie Waller Institute and Improving Access to Psychological Therapy. S.R. provides RO DBT supervision through her company S C Rushbrook Ltd. I.R. reports grants outside the submitted work from NIHR and Health & Care Research Wales. M. Stanton reports personal fees outside the submitted work from British Isles DBT Training, Stanton Psychological Services Ltd and Taylor & Francis. M. Swales reports personal fees outside the submitted work from British Isles DBT Training, Guilford Press, Oxford University Press and Taylor & Francis. B.W. was co-director of Radically Open Ltd between November 2014 and February 2015.

Sign in / Sign up

Export Citation Format

Share Document